NMD4C Investigators Dr Rashmi Kothary and Dr Natasha Chang Receive MDC Awards
We are excited to share that NMD4C investigators Dr Rashmi Kothary, and Dr Natasha Chang were recipients of the Dr George Karpati Award for Researcher of the Year and Rising Clinician/Researcher Award respectively from Muscular Dystrophy Canada (MDC) as a part of the Dr. David Green Recognition Program. This award program recognizes and celebrates the contributions of individuals and groups who champion neuromuscular disorders with courage, determination, passion and caring.
We are fortunate to have such dedicated and passionate members of the neuromuscular communtiy involved in our network, and congratulate both Dr Kothary and Dr Chang on their awards! The presentation of the Dr David Green awards took place at MDC’s Champions of Change Conference on November 4th in Calgary, AB.
Dr George Karpati Award for Researcher of the Year
Dr Rashmi Kothary
The Dr George Karpati Award for Researcher of the Year is presented to an exemplary neuromuscular researcher who has made a significant contribution to neuromuscular research, the advancement of care of people with neuromuscular disorders, or to MDC in the areas of public awareness, service and/or fundraising.
Dr Rashmi Kothary is the Deputy Scientific Director and Senior Scientist at the Ottawa Hospital Research Institute (OHRI). He received a Ph.D. in Biochemistry from the University of British Columbia and pursued postdoctoral research in the laboratories of Dr Janet Rossant at the Mount Sinai Hospital Research Institute in Toronto and Dr Azim Surani in Cambridge, U.K.
MDC is very honoured to have Dr Kothary’s support for the Neuromuscular Community, through his volunteer work with Muscular Dystrophy Canada relating to research, fundraising and programs and services. His experience in the research field has also benefitted the work of MDC through serving as a peer reviewer for MDC’s research grants and fellowship competitions. Dr Kothary has also shared his knowledge with the neuromuscular community by speaking during several MDC webinars. By serving as a Walk4MD Research Champion he also raised awareness and funds to support our mission. MDC is always pleased to partner with him, learn from him and leverage his expertise.
Rising Clinician/Researcher Award
Dr Natasha Chang
The Rising Clinician/Researcher Award is presented to a neuromuscular researcher or clinician, in the first five years of their career, who has shown significant potential for contribution to neuromuscular research, the advancement of care of people with neuromuscular disorders, or to MDC in the areas of knowledge translation, education/public awareness, advocacy, service and/or fundraising.
Dr Natasha Chang is an Assistant Professor in the Department of Biochemistry at McGill University. She obtained her Ph.D. with Dr Gordon Shore at McGill University studying BCL-2 family proteins and their role in regulating the cell survival autophagy pathway.
MDC appreciate Dr Chang’s commitment to the neuromuscular community through speaking at past MDC webinars, and conferences, while also playing an instrumental role in the NMD4C, where she actively contributes to the Early-Career Working Group and now sits on the network steering committee and co-leads the Pre-Clinical Science Pillar. Dr Chang brings a refreshed approach to her work in terms of multidisciplinary collaboration and influencing change with translational science research. She is truly a force and an emerging leader in neuromuscular research. MDC is always pleased to partner with her, learn from her and leverage her expertise.
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.